ReviewSynapse (New York, N.Y.)2026
Neuromodulatory Gating of Synaptic Plasticity: Mechanisms, Motivation, and Clinical Dysfunction Across Scales.
Review in Synapse (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain plasticity enables adaptive learning, memory, and behavior, yet it is neither unconstrained nor automatic. Emerging evidence indicates that synaptic change occurs within a hierarchy of interacting regulatory layers that collectively determine when, where, and how plasticity is expressed. We propose a four-layer hierarchical framework in which plasticity is shaped by energetic constraints, homeostatic stability, neuromodulatory gating, and experience-dependent synaptic modification. Energetic limits set metabolic boundaries for synaptic change, while homeostatic mechanisms maintain network excitability and excitation-inhibition balance. Neuromodulators, including dopamine, acetylcholine, noradrenaline, and serotonin, dynamically gate plasticity based on behavioral relevance, salience, and internal state. Finally, Hebbian and spike-timing-dependent mechanisms implement input-specific synaptic modifications that encode adaptive information. Dysregulation at any of these layers is proposed to contribute to clinical deficits: insufficient gating impairs learning and motivation, excessive or shifted gating balance stabilizes maladaptive circuits or distorts salience, and reduced consistency in gating dynamics undermines attention and flexibility. This perspective reframes neurological and psychiatric disorders as conditions of controlled plasticity failure (i.e., failure of one or more regulatory layers to appropriately permit or restrict synaptic change) rather than simple neurotransmitter imbalances. By integrating metabolic, cellular, circuit, and behavioral dimensions, our framework provides a mechanistic understanding of adaptive and maladaptive plasticity, offering principles to guide therapeutic interventions that restore context-appropriate learning and cognitive function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.